NM_000085.5:c.490G>T

HGVS Expressions

  • NG_013079.1:g.9285G>T
  • NM_000085.5:c.490G>T
  • NP_000076.2:p.Gly164Trp
  • NC_000001.11:g.16048036G>T
Back to search Result
CTGA Clinical Significance

Likely Pathogenic

Variant Type

Substitution

Epidemiology in the Arab World

View Map
Subject IDCountry of OriginAllele CountAllele FrequencyCTGA Clinical Significance Condition(s)ReferenceRemarks
607364.1.1United Arab Emirates2Likely PathogenicBartter Syndrome, Type 3; Gitelman SyndromeAl-Shibli et al. 2014 Patients from this Emirati family were c...
607364.1.2United Arab Emirates2Likely PathogenicBartter Syndrome, Type 3; Gitelman SyndromeAl-Shibli et al. 2014 Brother of 607364.1.1. Patients from thi...
607364.1.3United Arab Emirates2Likely PathogenicBartter Syndrome, Type 3; Gitelman SyndromeAl-Shibli et al. 2014 Cousin of 607364.1.1. Patients from this...
607364.1.4United Arab Emirates2Likely PathogenicBartter Syndrome, Type 3; Gitelman SyndromeAl-Shibli et al. 2014 Cousin of 607364.1.1. Patients from this...
607364.1.5United Arab Emirates1Al-Shibli et al. 2014 Father of 607364.1.1
607364.1.6United Arab Emirates1Al-Shibli et al. 2014 Mother of 607364.1.1
607364.1.7United Arab Emirates1Al-Shibli et al. 2014 Father of 607364.1.3
607364.1.8United Arab Emirates1Al-Shibli et al. 2014 Mother of 607364.1.3
© CAGS 2024. All rights reserved.